Eribulina Viatris

Eribulin Viatris is a chemotherapy medication used to treat certain types of cancer. It works by slowing or stopping cancer cell growth. Learn more about its uses and effects.

Eribulin Viatris is primarily used in the treatment of advanced breast cancer and liposarcoma. It is administered intravenously and is designed to interfere with the growth and spread of cancer cells. The medication is often considered when other treatments have not been effective. Eribulin is used for what is commonly referred to as metastatic breast cancer, which has spread to other parts of the body.

Common effects of Eribulin Viatris may include fatigue, nausea, and hair loss. Some patients may also experience fever, constipation, or peripheral neuropathy, which is a tingling or numbness in the hands and feet. These effects can vary in severity and may require management under medical supervision.

Eribulin Viatris should be handled with care and administered by healthcare professionals. It is important to follow all safety guidelines when using this medication. Patients should be monitored for any signs of infection or other complications. Proper storage and handling are crucial to ensure the medication's effectiveness and safety.

Eribulin Viatris may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how the medication works, so it is advisable to discuss these factors with a healthcare professional.